Eric Vivier, DVM, PhD, is a professor of immunology at Aix-Marseille University, France.
He graduated with the highest honors (silver medal) from the Ecole Nationale Vétérinaire de Maisons-Alfort and received his doctoral degree in immunology from Paris XI University.
He began his postdoctoral training as a Fogarty International Center Research Fellow at Harvard Medical School with Paul J. Anderson and Stuart F. Schlossman (the Dana-Farber Cancer Institute).
He joined Aix-Marseille University as a professor at the Centre d'Immunologie de Marseille-Luminy (CIML) in 1993 and became its director in 2008.
In 1999, Dr. Vivier cofounded the biotech company Innate-Pharma.
In 2014, he was one of the founders of the Marseille-Immunopole, an immunology cluster linking fundamental research, therapeutic innovation, and industrial development in the Aix-Marseille region.
The Vivier laboratory has since been a world leader in the generation of transgenic mouse models for the dissection of NK-cell function in vivo. Building on these basic research results, the Vivier laboratory has also been involved in the development of innovative treatments for cancer.
These studies on NK cells led to the involvement of the Vivier laboratory in the discovery of ILCs through the detection and characterization of the ILC3 cell subset in human and mouse intestine.
Dr. Vivier has published more than 300 scientific articles and is on the editorial boards of leading peer-reviewed journals.
In recognition of his scientific achievements, Dr. Vivier has received awards from:
- the French National League against Cancer (1996, 2004, and 2013),
- the National Award and Tremplins Rhône-Poulenc Award for Biotech start-ups (1999),
- the Lucien Tartois Award from the Fondation pour la Recherche Médicale (1999),
- the Jacques Oudin Award from the French Society for Immunology (2003),
- the Deutsche Gesellschaft für Immunologie/EFIS Award (2004),
- the Grand Prix Turpin in Oncology (2008),
- the Grand Prix Charles Oberling in Oncology (2010),
In 2007, Dr. Vivier became a senior fellow of the Institut Universitaire de France, and, in 2013, he was elected to the French National Academy of Medicine.
« Go Back